Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
07.05.Eli Lilly and Alchemab Therapeutics enter ALS agreement worth up to $415m
07.05.Johnson & Johnson shares long-term results for Tremfya in ulcerative colitis
07.05.MHRA approves Bavarian Nordic's chikungunya vaccine Vimkunya
06.05.AstraZeneca's Calquence approved by EC for first-line mantle cell lymphoma use
06.05.Bristol Myers Squibb's injectable Opdivo formulation granted MHRA for solid tumours
06.05.Alnylam's RNAi therapeutic vutrisiran recommended by CHMP for rare heart disease
02.05.Johnson & Johnson's Imaavy granted FDA approval for rare autoimmune disease gMG
02.05.NHS patients to access Theramex's endometriosis pill following NICE recommendation
02.05.AstraZeneca's triple-combination COPD therapy shows promise in uncontrolled asthma
01.05.Novartis to expand renal disease pipeline with $1.7bn Regulus acquisition
01.05.FDA approves Abeona's epidermolysis bullosa gene therapy Zevaskyn
01.05.UK government's AMR study highlights importance of appropriate antibiotic use
01.05.IPG Health announces evolution of medical communications offering
01.05.Medical remote monitoring: a revolution driven by connected patches
30.04.Eli Lilly and Creyon Bio enter oligonucleotide therapy partnership worth over $1bn
30.04.AbbVie's JAK inhibitor Rinvoq granted FDA approval to treat giant cell arteritis
30.04.AstraZeneca's Calquence regimens recommended by CHMP for chronic lymphocytic leukaemia
30.04.Mastering pharma capability development cogs
29.04.Regeneron's bispecific antibody Lynozyfic approved by EC to treat multiple myeloma
29.04.MHRA approves Autolus Therapeutics' Aucatzyl to treat acute lymphoblastic leukaemia
29.04.Takeda receives CHMP recommendation for Adcetris in Hodgkin lymphoma
29.04.Client/agency partnerships - a marriage of science and creativity
28.04.Merck KGaA expands rare tumour portfolio with $3.9bn SpringWorks acquisition
28.04.Roche to boost US footprint with $50bn investment over next five years
28.04.Pfizer's sasanlimab improves event-free survival in phase 3 bladder cancer trial